Leroyine - Compound Card

Leroyine

Select a section from the left sidebar

Leroyine

Structure
Zoomed Structure
  • Family: Plantae - Ranunculaceae
  • Kingdom: Plantae
  • Class: Alkaloid
    • Subclass: Norditerpenoid Alkaloid
Canonical Smiles CO[C@@H]1C[C@@]2(O)[C@H]3[C@H]([C@@H]1C[C@H]3[C@@]13[C@H]4[C@]2(O)C[C@@H]1[C@@](CN4CC)(C)CC[C@@H]3O)O
InChI InChI=1S/C22H35NO5/c1-4-23-10-19(2)6-5-15(24)22-12-7-11-13(28-3)8-20(26,16(12)17(11)25)21(27,18(22)23)9-14(19)22/h11-18,24-27H,4-10H2,1-3H3/t11-,12-,13-,14-,15+,16-,17+,18-,19+,20-,21-,22-/m1/s1
InChIKey XBAVRWWMTJPXJW-RICCOQTBSA-N
Formula C22H35NO5
HBA 6
HBD 4
MW 393.52
Rotatable Bonds 2
TPSA 93.39
LogP 0.37
Number Rings 6
Number Aromatic Rings 0
Heavy Atom Count 28
Formal Charge 0
Fraction CSP3 1.0
Exact Mass 393.25
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Delphinium leroyi Ranunculaceae Plantae 1127171

Showing of synonyms

  • Bai Y, Benn M. (1992). Norditerpenoid alkaloids of Delphinium leroyi. Phytochemistry,1992,31(9),3243-3245. [View] [PubMed]
Pubchem: 101631697

No compound-protein relationship available.

Structure

SMILES: C1C(C2)CCC(C2C1C345)C6C3NCC(C4C6)CCC5

Level: 0

Mol. Weight: 393.52 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-5.15
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-5.450
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
-0.81

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.380
Plasma Protein Binding
59.48
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
3.510
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-2.850
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-1.110
Liver Injury II
Safe
hERG Blockers
Toxic
Daphnia Maga
5.210
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-19.840
Rat (Acute)
3.360
Rat (Chronic Oral)
2.550
Fathead Minnow
3.180
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
431.000
Hydration Free Energy
-6.980
Log(D) at pH=7.4
1.150
Log(P)
1.02
Log S
-2.42
Log(Vapor Pressure)
-11.31
Melting Point
173.68
pKa Acid
6.67
pKa Basic
8.37
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
CmeR Q7B8P6 Q7B8P6_CAMJU Campylobacter jejuni 3 0.8740
CmeR Q7B8P6 Q7B8P6_CAMJU Campylobacter jejuni 3 0.8740
Prolyl tripeptidyl peptidase Q7MUW6 PTP_PORGI Porphyromonas gingivalis 3 0.7156
Prolyl tripeptidyl peptidase Q7MUW6 PTP_PORGI Porphyromonas gingivalis 3 0.7156

Download SDF